−50.9
Entrada Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−93.8
FY23:
140
FY24:
−41.6
FY25:
−129
Change from FY21 to FY25
millions USD
FY21:
−4.58
FY22:
−149
FY23:
−138
FY24:
−27.8
FY25:
117
Change from FY21 to FY25
millions USD
FY21:
307
FY22:
0.48
FY23:
21.0
FY24:
103
FY25:
0.89
millions USD
FY21:
252
FY22:
−242
FY23:
22.4
FY24:
33.6
FY25:
−10.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−55.4
FY22:
−96.7
FY23:
134
FY24:
−44.7
FY25:
−130
All amounts in millions USD